What question did this study set out to answer?

Determine whether the autophagy-enhancing drug carbamazepine can promote the clearance of toxic mutant alpha1-antitrypsin Z protein and reduce liver fibrosis.

June 3, 2010Science

An Autophagy-Enhancing Drug Promotes Degradation of Mutant α ₁ -Antitrypsin Z and Reduces Hepatic Fibrosis

View Full Paper

Ask AI

Bookmark

Authors

THTunda HidvegiJames S. McDonnell Foundation MEMichael EwingUniversity of Pittsburgh Medical Center PHPamela HaleSt Vincent's Hospital

Discussion

Member takes

Implication

Animal study demonstrates carbamazepine decreases mutant protein accumulation and hepatic fibrosis in alpha1-antitrypsin deficiency mice, suggesting therapeutic potential for autophagy enhancers.

Key Points

Determine whether the autophagy-enhancing drug carbamazepine can promote the clearance of toxic mutant alpha1-antitrypsin Z protein and reduce liver fibrosis.
Administered the clinical autophagy-enhancing drug carbamazepine to a transgenic mouse model of alpha1-antitrypsin deficiency-associated liver disease.
Assessed hepatic levels of the aggregation-prone mutant alpha1-antitrypsin Z variant and quantified changes in liver fibrosis.
Carbamazepine administration led to a marked reduction in the intrahepatic burden of mutant alpha1-antitrypsin Z protein.
Accelerated clearance of the misfolded glycoprotein was associated with a significant decrease in hepatic fibrosis.

Cite This Study

Hidvegi et al. (2010) studied this question.

synapsesocial.com/papers/69dd06c67d2a65005be52e47 https://doi.org/10.1126/science.1190354

View Full Paper

Ask AI

Bookmark

Implication

Animal study demonstrates carbamazepine decreases mutant protein accumulation and hepatic fibrosis in alpha1-antitrypsin deficiency mice, suggesting therapeutic potential for autophagy enhancers.

An Autophagy-Enhancing Drug Promotes Degradation of Mutant α ₁ -Antitrypsin Z and Reduces Hepatic Fibrosis

Discussion

Member takes

Implication

Key Points

Cite This Study

An Autophagy-Enhancing Drug Promotes Degradation of Mutant α ₁ -Antitrypsin Z and Reduces Hepatic Fibrosis

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider